relatively normal outside of the obesity syndrome, with only mild hypotension and hyperinsulinaemia being reported. Another unique feature of the central melanocortin system are the gene dosage effects for MC4R, 8, 12 a highly unusual finding for G protein-coupled receptor signalling systems.
Thus, the MC4R is a well-validated target for the treatment of common obesity 8, 9 and cachexia. [13] [14] [15] [16] Other studies suggest potential applications in diabetes 7, 17, 18 and the metabolic syndrome, 19, 20 depression-related anorexia and anhedonia, 21 and obsessive-compulsive disorder. 22 The MC4R appears to be at the heart of the adipostat, in that administration of melanocortin agonists inhibits food intake 12 and increases energy expenditure. 23 Chronic administration of potent melanocortin agonists produces significant weight loss in model systems, from rodents to primates. 24 However, clinical trials of potent small molecule orthosteric agonists of the MC4R have failed as a result of target-mediated pressor effects.
Despite the target-mediated pressor response resulting from most melanocortin agonists, two peptide analogues of the native MC4R
ligand, α-melanocyte-stimulating hormone (α-MSH), have been demonstrated to cause weight loss without a pressor response.
24-27
One of these compounds, setmelanotide, has been used successfully in a clinical trial in two patients with compound heterozygous mutations in pro-opiomelanocortin (POMC), the preprohormone precursor for α-MSH, 24 and in a clinical trial in patients with homozygous mutations in the gene encoding the leptin receptor. 28 There are no data available explaining why some MC4R agonists are capable of inducing weight loss without the target-mediated pressor response, although biased agonism must be considered in the event that multiple signalling pathways are activated downstream of MC4R.
In this regard, it is already appreciated that MC4R exhibits different signalling modalities on the cellular level in vivo. The MC4R couples to Gα S in all cells tested, and it has been demonstrated that deletion of Gα S from MC4R neurones recapitulates the phenotype seen in MC4R knockout mice. 29 However, the complexity of MC4R signalling in vivo is also clear. α-MSH activates MC4R positive intermediolateral nucleus neurones via a putative nonspecific cation channel, 30 whereas it inhibits MC4R neurones in the dorsal motor nucleus of the vagus nerve via activation of a K ATP channel. 31 Recently, using a hypothalamic slice preparation in the mouse, we demonstrated that α-MSH appears to depolarise and activate MC4R neurones in the paraventricular nucleus (PVN) via a G protein-independent mechanism involving inhibition of the inward rectifier channel Kir7. 1. 32 This is a highly unusual finding, requiring further validation in vivo. Furthermore, a better understanding of the role(s) of variant MC4R signalling modalities in vivo might lead to a rationale pharmacological approach for the development of small molecule biased agonists of MC4R that could discriminate between weight loss and pressor activities. Aiming toward these two goals, we specifically deleted the inward rectifier Kir7.1 from MC4R cells in the mouse and conducted pharmacological and physiological studies on the resulting animals.
| MATERIAL S AND ME THODS

| Mouse strains and genotyping
We used promoter-driven, knockout-first, Kcnj13 targeted selec- 
| Mouse handling
All mice were housed under standard, infection-free housing conditions under a 12:12 hour dark cycle at 25°C. The strictly pathogenfree quality of the mouse colonies was maintained through quarterly serology, quarterly histopathologic examinations, as well as daily veterinarian monitoring of the general health and welfare of animals.
Male and female mice were used for these experimental procedures.
Mice were weaned at 4 weeks of age and maintained with four or five mice per cage, unless the animals were used for feeding studies. Animals used in feeding analysis were singly housed for acute studies and dually housed for long-term feeding studies. Unless otherwise described, all mice were fed a standard chow diet (Lab Diet; Brain blocks containing hypothalamus were made by trimming whole brains when the brains were immersed in oxygenated, near-freezing aCSF and glued to a dental-cement cast customised to the size of the block mounted on a plate with adjustable angle. Brain slices of 200 μm in thicknesses were then cut at an angle range between 44°
and 49° in reference to the horizontal plane and transferred to a glass beaker containing oxygenated aCSF at 31°C. After an incubation period lasting at least 1 hour, a slice was transferred to a recording chamber (approximately 2.0 mL in volume), then submerged and immobilised with nylon strands drawn taut across a C-shaped platinum wire (outer diameter 1 mm) and perfused with warmed (31-32°C) oxygenated aCSF at a rate of 2-3 mL min -1 . Enhanced GFP-fluorescent neurones were unambiguously identified and patched using combined epifluorescence and infrared-differential interference contrast (IR-DIC) optics. Fluorescent neurones of healthy IR-DIC appearance but of every level of fluorescence brightness were chosen for electrophysiological recordings. Drugs were added to aCSF and bath applied to the slice via the perfusion system for extracellular application. The small volume of the recording chamber relative to the flow rate assured a complete exchange of solution occurring in less than 1 minute. The persisting effects of a peptide were therefore a result of prolonged effects rather than a slow wash out.
In the present study, whole-cell patch-clamp recordings were used to obtain information about action potential firing activity, as well as membrane potentials and currents. Unless stated otherwise, whole-cell recordings were performed using patch pipettes of Figure S3 ) was cloned into pLKO.1 expressing mCherry. 
| Fast-induced refeeding
| Cannulation surgery for i.c.v. injection
To investigate the effect of i.c.v. injection of AgRP, mice were anaesthetised with isoflurane and a stainless-steel cannula (Plastics One) was surgically implanted into the right lateral ventricle using the stereotaxic coordinates of 0.46 mm posterior to the bregma, analyser (Luminex Corp., Austin, TX, USA). The results were analysed against a standard curve and concentrations were determined using milliplex analyst, version 5.1 (Merck). Values were plotted and analysed using prism (GraphPad Software Inc., San Diego, CA, USA).
| Plasma hormone measurements
Statistical analyses were conducted using multiple t tests.
| Growth phenotyping
Male and female mice were dually housed with same sex, same genotype animals of similar weight to collect weekly food intake (standard chow or diet-induced obesity [DIO]) and growth data. Mouse lean and fat mass body composition was obtained by NMR (mq10 Minispec; Bruker, Billericia, MA, USA).
| Metabolic studies
Glucose tolerance testing was conducted as described previously. 34 Three days prior to the glucose tolerance test (GTT), the body composition was obtained to determine the lean body mass. Mice were then habituated to consecutive, daily handling sessions. On the study day, mice were fasted for 6 hours (from 9:00 am to 3:00 pm).
Mice were scruffed to obtain a basal glucose read by tail nick, then injected with 1 (DIO) to 2 (chow) mg kg -1 lean mass dose of glucose in sterile phosphate-buffered saline. Tail vein bleeding was performed at 15, 30, 45 60, 90 and 120 minutes after the injections. Glucose readings were obtained by tail vein bleeds at the times indicated.
Glucose was measured using Aviva PLUS Glucose test Strips (Roche Diagnostics). Lean mass was determined by a NMR body composition scan (mq10 Minispec; Bruker). Repeated sampling by tail vein bleeding was carried out at intervals at least 1 week apart to allow for a complete recovery from blood loss. The area under the curve was calculated using the trapezoidal rule.
| Statistical analysis
Sample size for growth curve studies was chosen using the power equation (α < 0.05, β = 0.1, Δμ = 25% σ = 5), whereas sample sizes for the remaining studies were estimated based on previous publications.
All statistical tests were conducted using prism, version 6 (Scientific Software, La Jolla, CA, USA). Data are presented as the mean ± SE of the mean. P < 0.05 was considered statistically significant. Experimental performers were generally blinded for the initial studies and partially blinded for genotype identity for the repeated studies. Experiments were repeated at least three times with age-and litter-matched animals across the experimental and control groups.
| RE SULTS
| Global and tissue-specific deletion of Kcnj13
To analyse the potential roles of Kir7.1 in MC4R neurones in vivo,
we developed a versatile, transgenic mouse strategy (see Supporting information, Figure S1 ) using the KOMP mutant allele repository.
After germ line transmission, the first generation mutant was a homozygous, global null mouse (Kcnj13 KO ). As previously reported using a Velocigene method, we confirmed that the Kcnj13 KO resulted in early (P0) postnatal lethality (see Supporting information, Figure   S2 ). 35 Pathological analyses indicated retardation of lung and kidney Despite the powerful drive to restore energy stores resulting from a state of nutritional deficit, LY2112688 blunted the fasting-induced refeeding response in control genotype groups; however, in Kcnj13ΔMC4RCre male ( Figure 2A ) and female ( Figure 2B) The study paradigm was repeated using male mice following bilateral lentiviral Kcnj13 shRNA knockdown, or administration of a scrambled control lentivirus in the PVN (sc shRNA). Three different lentivirus constructs designed to knockdown Kcnj13 were purchased and tested for efficacy using HEK293 cells expressing Kcnj13 (see Supporting information, Figure S3) . A virus yielding >70% reduction in Kcnj13 mRNA levels (clone #99) was selected for these experiments. After 3 weeks of recovery, mice were acclimated to handling and injection before beginning the fast-induced refeeding study ( Figure 2C ). Similar to genetic deletion of Kir7.1, viral knockdown of Kir7.1 exclusively in the PVN also reduced the duration of the anorectic activity of LY2112688.
LY2112688 was no longer effective at reducing food intake com- Taken together, these data show that Kir7.1 expression was required for the extended duration of anorectic response to a melanocortin peptide.
We have previously shown the role of Kir7.1 in mediating a G protein-independent MC4R response in both hypothalamic slices and in cells transfected with MC4R and Kir7. 
Kcnj13ΔMC4R
Cre male mice, and animals were allowed to recover for 5 days. Two days after a saline injection to establish baseline conditions, 2 nmol of the peptide AgRP was injected i.c.v. during the light cycle. We observed no significant difference in central AgRP-induced feeding initiation or duration between genotypes (see Supporting information, Figure S4A ), suggesting that Kir7.1
was not required for the orexigenic response to AgRP. Likewise, all genotypes responded to AgRP with an increase in body weight in proportion to the increase in food intake (see Supporting information, Figure S4B ). There was no significant difference in change in body weight between genotypes.
| Normal melanocortin-stimulated PYY release in Kcnj13ΔMC4R Cre mice
Although MC4R is expressed in many brain nuclei, peripheral expression has also been mapped. Notably, MC4R is expressed in 
| Phenotypic characterisation of
Kcnj13ΔMC4R
Cre mice we did not observe differences in body weight in the four strains maintained on normal mouse chow ( Figure 4A,B) . Moreover, when lean and fat mass accrual are compared in young 12 week old mice and mature mice, no significant difference was detected in lean or fat mass between groups ( Figure 4D-G) . However, by 26 weeks of age in female mice and 50 weeks of age in male mice, Kcnj13ΔMC4RCre animals show significantly greater weight compared to all three control strains ( Figure 4A,B) . One-way ANOVA
showed that Kcnj13ΔMC4RCre male and female mice gained per group, *P < 0.05, **P < 0.005, ****P < 0.0001, two-way ANOVA with multiple comparisons test). NS, not significant 
F I G U R E 4 Late onset obesity develops in chow fed Kcnj13ΔMC4R
Cre mice. Growth curves on chow diet of (A) male and (B) female mice interspersed across three age cohorts from 9 to 63 weeks. One-way ANOVA shows Kcnj13ΔMC4RCre male and female mice gained significantly more weight over the time course than the control genotypes. C, D, Snout-to anus length of euthanised female (C) and male (D) Kcnj13ΔMC4RCre, Kcnj13 fl/fl, Kcnj13+/+;MC4RCre, and Kcnj13+/+;MC4R+/+ mice at the age of approximately 30 weeks. Each dot represents the snout-anus distance of one individual animal (n = 6-25 per group, **P < 0.005, ****P < 0.0001, multiple t test with HolmSidak post-hoc test). E, Daily chow consumption per mouse at mouse age indicated in weeks. One-way ANOVA test with Tukey's multiple comparisons. Absolute fat (F) and lean (G) mass and %fat (H) and %lean (I) mass body composition of 12-, 22-and 28-week-old female mice.
Multiple t tests with Holms-Sidak multiple comparison test. (J-L) Plasma glucose concentration during i.p. glucose tolerance test (IPGTT).
Glucose (2 g kg -1 ), normalised to % lean body mass, was administered to each animal. IPGTT was performed after 6 h of daytime fasting in 28-week-old female animals. Comparison of the difference in total area under the curve (AUC) shows (K) AUC from 0 to 120 is similar, whereas Kcnj13ΔMC4R Cre mice differ significantly from control genotypes from (L) 45-120 min. J, multiple t tests, (K-L) One-way ANOVA with multiple comparisons (n = 6-12 per group, *P < 0.05, **P < 0.005, ***P < 0.0005, ****P < 0.0001) 
F I G U R E 5 Obesity and glucose intolerance in Kcnj13ΔMC4R
Cre mice on a high-fat diet (HFD). Growth curves on a HFD from (A) male and (C) female mice (n = 
significantly more weight over the time course than the control genotypes. No significant difference was observed in daily chow consumption between groups ( Figure 4C ). Using indirect calorimetry, no significant difference was observed in energy expenditure among the four strains (data not shown). At 28 weeks of age, female Kcnj13ΔMC4RCre mice weight were observed to have significantly more absolute and %fat mass compared to control genotypes ( Figure 4D,F) , whereas lean mass was unchanged ( Figure 4E ).
Both male and female 30 week old Kcnj13ΔMC4RCre animals also exhibited increased length relative to all controls ( Figure 4C-D) , as is observed in MC4RKO mice and humans. The % lean mass ( Figure 4G ) was lower in Kcnj13ΔMC4RCre mice as a result of the increase in adipose mass. controls. Female weight gain tended to be higher, and was also significantly different on HFD using Student's t tests at individual time points from 70 to 84 days ( Figure 5C ). We were unable to measure an effect of any genotype on food intake ( Figure 5B,D) . After consuming a HFD for 3 months, there is a significant increase in fat mass in both Kcnj13ΔMC4RCre and Kcnj13+/+;MC4RCre groups ( Figure 5E-H) ; however, we were unable to measure an effect of 
| D ISCUSS I ON
MC4R is known to signal through the Gαs-cAMP signalling pathway in cell assays and in vivo. 29, 37 However, our data on MC4R signalling in a hypothalamic slice preparation from the mouse suggested that the MC4R depolarises neurones in the PVN via G protein-independent regulation of the inward rectifier Kir7.1. 32 To assess the potential physiological role of this MC4R-Kir7.1 signalling pathway, we used
Cre-loxP technology to delete Kir7.1 from MC4R-expressing cells in the mouse, and investigated the consequences on MC4R signalling, as well as on MC4R-mediated physiological responses.
Homozygous loss of Kir7.1 is known to cause degenerative eye diseases such as snowflake vitreoretinal degeneration and Leber congenital amaurosis 38, 39 in humans, and a pigmentary defect in the jaguar zebrafish, 40 and thus we anticipated being able to conduct our studies in the global Kir7.1 knockout mouse. Surprisingly, however, we discovered that homozygous deletion of Kir7.1 in the mouse caused perinatal lethality. Histological analysis demonstrated stunted lung and kidney development, as well as reduced body mass (see Supporting information, Figure S2 ), and this same finding was reported by another laboratory. 35 It is unclear why Kir7.1 is an essential developmental gene in the mouse but not zebrafish or humans, although the observation suggests variable physiological functions of this channel in different species.
After proceeding through a breeding strategy to obtain animals with a floxed Kcnj13 allele, we generated animals with MC4R-site-specific deletion of Kir7.1. Because Kir7.1 is expressed at very low levels in the sparsely distributed MC4R neurones, 32 we were unable to readily validate the absence of Kir7.1 mRNA from MC4R neurones. Recording from MC4R labelled cells in the PVN is a well-established tool for characterising MC4R firing activity. 41 Likewise, the depolarisation signature of MC4R cells via closure of Kir7.1 has been defined in the slice preparation. This study parallels prior work using a Tl + flux assay in HEK293 cells expressing MC4R and Kir7.1 to characterise the regulation of ion flux through Kir7.1 mediated by MC4R. 44 These data suggested that the G protein-mediated cAMP response peaks rapidly after α-MSH exposure, whereas inhibition of Tl+ flux through Kir7.1 continued long after the cAMP response ebbed. 32 Although our data clearly demonstrated pharmacological defects in response to melanocortin agonists in the absence of Kir7.1, it would also be interesting to examine the effects of chronic optogenetic stimulation of
POMC neurones in the Kcnj13ΔMC4R
Cre mouse, given the delayed anorexigenic response observed in this assay.
AgRP engages the MC4R at high affinity but does not couple the receptor to G proteins or stimulate arrestin recruitment. 45 an as yet unidentified mechanism.
48-50
Not only is MC4R widely expressed in the CNS, but also sites of peripheral expression have been detected, namely in the peripheral nervous system and enteroendocrine L cells. 36, 37, 51, 52 Using an assay for detecting MC4R-dependent L-cell release of PYY in response to exogenous administration of the α-MSH analogue LY2112688, we found that the absence of Kir7.1 in MC4R cells has no effect on PYY release ( Figure 3 ). These data clearly showed that MC4R induces PYY release in a Kir7. Nonetheless, when Kir7.1 was ablated from MC4R cells, male and female mice were more sensitive to diet-induced weight gain than the Kcnj13+/+; MC4RCre controls ( Figure 5A , C). This did not appear to be the result of a sustained measurable hyperphagic response ( Figure 5B, D) . A comparison of body mass composition by NMR reveals a significant increase in fat mass in both male and female
Kcnj13ΔMC4R
Cre animals compared to Kcnj13+/+ and Kcnj13 fl/fl controls but not compared to Kcnj13+/+;MC4RCre ( Figure 5E-H) . Given the significant increase in total weight, we hypothesise that the lack of a difference in fat mass in Kcnj13ΔMC4R Cre animals vs controls may be the result of a lack of sensitivity of the whole animal NMR method. suggests that Kir7.1 may also augment MC4R signalling in autonomic nervous system pathways regulating glucose homeostasis.
The data reported in the present study show a measurable requirement for Kir7.1 in MC4R neurones for pharmacological responses to melanocortin agonists but not antagonists. In particular, Kir7.1 may be required for sustained responses to pharmacotherapy with melanocortin agonists such as setmelanotide. It will be informative to determine whether the delayed anorexigenic effect of optogenetic stimulation of POMC neurones requires Kir7.1. Likewise, given the apparent role of Kir7.1 in sustained anorexia, it may be informative to investigate the role of Kir7.1 in mediating the demonstrated role of MC4R signalling in disease cachexia in the mouse. 56 Similarly, other physiological responses to melanocortins, such as those involved in the control of glucose homeostasis, may depend on Kir7.1.
We were surprised to note the very modest effect of Kir7.1 on body weight, as well as the divergence of the phenotype from that seen in MC4R knockout mice and patients with MC4R mutations. There are many potential explanations for these findings, including changes that compensate early on for the absence of Kir7.1. Recently, a rather dramatic example was reported illustrating the tremendous compensatory plasticity of the melanocortin circuits in response to early developmental gene knockout. 57 Deletion of leptin receptor from AgRP neurones is found to produce only a minor obesity and diabetes phenotype, 58 relative to global leptin receptor deletion. By contrast, CRISPR-mediated deletion of the gene in AgRP neurones in adult animals produced a morbid obesity syndrome almost paralleling that seen in the db/db mouse. 57 Even more relevant to the present study, leptin hyperpolarises neurones by opening the K ATP channel. 59 Although global deletion of the Kir6.2 subunit of this channel had a limited effect on glucose homeostasis and no obesogenic effect, 60,61 CRISPR-mediated mutagenesis of Kir6.2 in AgRP neurones alone yielded a morbid obesity syndrome with diabetes. 57 Thus, it is possible that a wholly different phenotype may be seen upon deletion of Kir7.1 in the adult mouse.
Alternatively, the results reported in the present study may indicate that Kir7.1 plays a very specific and limited role in the physiological functioning of the MC4R. Additionally, the data obtained do not rule out the possibility that the phenotype results from a minor developmental alteration in a subset of MC4R neurones.
Furthermore, we provide a direct example of a physiologically-mediated MC4R pathway, PYY release, from L cells, which appears to be Kir7.1-independent. Interestingly, irrespective of the physiological role(s) for Kir7.1 in MC4R signalling, the present study demonstrates a significant pharmacological effect of Kir7.1 in vivo and in the slice preparation. These data may thus be important for the ongoing challenge with respect to the development of therapeutics acting at the MC4R, further highlighting the complexities of MC4R signalling that remain to be solved. 
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